Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591953 · ClinicalTrials.gov registry record · NA
Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02591953 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 22 participants.
The verdict
NCT02591953, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Using randomization, prospectively determine superiority of either ultrasound-guided or landmark-guided biceps corticosteroid injections with regard to various clinical variables.
Interventions
- DRUG Methylprednisolone
- DRUG Lidocaine 1%
- PROCEDURE Ultrasound-guidance
- PROCEDURE Landmark-guidance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02591953
The ClinicalTrials.gov registry entry for NCT02591953 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Methylprednisolone is the first listed.
NCT02591953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02591953 about?
NCT02591953 is a clinical study titled "Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections". Using randomization, prospectively determine superiority of either ultrasound-guided or landmark-guided biceps corticosteroid injections with regard to various clinical variables.
What is the current status of trial NCT02591953?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2015-11. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02591953?
The interventions under investigation include: Methylprednisolone (DRUG), Lidocaine 1% (DRUG), Ultrasound-guidance (PROCEDURE), Landmark-guidance (PROCEDURE).
Who is sponsoring clinical trial NCT02591953?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.